This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Jump to section
Related Articles
Cited By...
- Bexarotene via CBP/p300 Induces Suppression of NF-{kappa}B-Dependent Cell Growth and Invasion in Thyroid Cancer
- Standard and Emerging Therapies for Metastatic Differentiated Thyroid Cancer
- Enhanced Expression of Adenovirus-Mediated Sodium Iodide Symporter Gene in MCF-7 Breast Cancer Cells with Retinoic Acid Treatment
- Enhancement of sodium/iodide symporter expression in thyroid and breast cancer.
- Diagnostic Accuracy and Prognostic Value of 18F-FDG PET in Hurthle Cell Thyroid Cancer Patients
- Action of thiazolidinediones on differentiation, proliferation and apoptosis of normal and transformed thyrocytes in culture
- Sodium Iodide Symporter: Its Role in Nuclear Medicine
- Advances in radionuclide imaging: radionuclide imaging as a guide to therapy
- Clinical Usefulness of FDG PET in Differentiated Thyroid Cancer
- FDG PET in Thyroid Cancer: Thyroxine or Not?